The Board’s position is that whenever possible, avoid providing care (including prescribing) to family, friends and colleagues, because in most cases it is inappropriate. We do see the Board taking action in notifications about the provision of such care (particularly outside a formal consultation). Care can be negatively impacted because of:
- a lack of objectivity
- the possibility of inadequate or incomplete assessment with no medical records
- discontinuity of care
- the patient feeling uncomfortable sharing sensitive information
- principles of informed consent that may not be followed.
Additionally, practitioners risk breaching the specific, varying, and complex legislative restrictions on self (and family) prescribing in the various jurisdictions. This ranges from full self-prescribing prohibition (Victoria) through restrictions on self-prescribing Schedule 8 drugs (most jurisdictions) and some Schedule 4 medicines (Queensland, ACT, NSW, potentially WA/NT); or prescribing Schedule 8 drugs to classes of relative (SA). Such breaches may be criminal offences.
MDA National is well aware of regulatory authorities, such as Ahpra, taking action against practitioners who prescribe to close friends, family, and those they work with. Pharmaceutical regulatory authorities regularly audit prescribing and do report breaches of their prescribing legislation to regulatory bodies.